
SomnoMed Investor Relations Material
Latest events

H1 2025
SomnoMed
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from SomnoMed Limited
Access all reports
SomnoMed Limited is an Australian-based medical device company, publicly listed on the Australian Stock Exchange, specializing in the development and manufacturing of oral devices for the treatment of obstructive sleep apnea (OSA) and other sleep-related disorders. The company's product portfolio includes a range of custom-made oral appliances such as the SomnoDent series (Avant, Classic, Flex, Fusion, Herbst Advance Elite, and Herbst Advance), SomMorning Repositioner, SomnoBrux, and SomTabs for cleaning oral appliances. The company is headquartered in Sydney, Australia, and its shares are listed on the Australian Stock Exchange.
Key slides for SomnoMed Limited


H1 2025
SomnoMed Limited


H1 2025
SomnoMed Limited
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
SOM
Country
🇦🇺 Australia